Viewing Study NCT05986851


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-22 @ 9:37 AM
Study NCT ID: NCT05986851
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-09-05
First Post: 2023-08-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Azeliragon in MGMT Unmethylated Glioblastoma
Sponsor: Cantex Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module